Furthermore, scDb-hERG1-β1-TRAIL showed a good pharmacokinetic and toxicologic profile in vivo, accumulated into tumor masses arising from TNBC cells and strongly reducing their growth by inducing apoptotic death. This evidence concerns the gene TNFSF10 and neoplasm.